Mendel.ai enhances clinical data analysis in healthcare, particularly in oncology research and clinical trials, by using artificial intelligence to match cancer patients with suitable clinical trials more efficiently. The company provides an AI-powered platform that allows clients, including researchers and pharmaceutical companies, to quickly analyze large datasets, such as electronic medical records and genetic information. Mendel.ai differentiates itself by offering a subscription-based model for its tools and customized solutions, focusing on real-world evidence and data. The goal is to improve the efficiency and accuracy of clinical trials, ultimately leading to better patient outcomes.

DCM Ventures

Oak HC/FT

SOSV

Millennium Technology Value Partners

Launch Capital

Mark Goldstein

Olive Tree Capital

Zola Global

BootstrapLabs

Indie Bio

LaunchCapital

Enterprise Software

AI & Machine Learning

Healthcare

Mendel.ai

Karim Galil, Co-Founder and Chief Executive Officer of Mendel AIUntil recently, the term “symbolic” bore negative connotations in AI because it harkened back to the failures to achieve symbolic thinking during the so-called “AI winter” of the 1980s. Since then, generative AI has demonstrated the masterly capacities of neural networks at scale.Generative AI has relieved doctors of their administrative and cognitive burdens, for example, by handling administration and paperwork, including clinical summaries. More than 70 percent of healthcare organizations are pursuing generative AI capabilities, according to McKinsey. Today, however, we see generative AI’s deficiencies, especially in medicine. It can behave like a parrot, mindlessly telling users whatever its blind algorithms have told it to say. They also “hallucinate” or invent data, unacceptably compromising care and research.AI-generated clinical summaries don’t necessarily come under FDA oversight on standards and could cause more harm than benefits, according to JAMA. These concerns are partly why large multinational technology companies have abandoned many AI-powered healthcare efforts in recent years

Neuro-Symbolic Ai In Healthcare: Unlocking Precision Medicine

To offer customers a hands-on experience, Mendel AI has launched TryMe, a trial environment accessible on its website.

Mendel AI's Hypercube Platform Now Available on Snowflake, Transforming Clinical Data Analysis

Mendel AI's Hypercube platform, integrated with Snowflake's Data Cloud, is set to redefine how clinical data analysis is approached, bringing about greater efficiency, accuracy, and new insights in the medical field.

Mendel AI's Hypercube on Snowflake Revolutionizes Clinical Data Analysis

Microsoft Azure customers worldwide now gain access to Mendel's Hypercube Platform to leverage advanced AI-driven clinical data analytics, enhancing healthcare decision-making with the scalability, reliability, and agility of Azure to drive application development and shape business strategies.SAN JOSE, Calif., Sept. 3, 2024 /PRNewswire/ -- Mendel, a leader in clinical artificial intelligence, today announced the availability of the Hypercube Platform in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. Mendel customers can now take advantage of the productive and trusted Azure cloud platform, with streamlined deployment and management.Mendel's Hypercube Platform is a comprehensive clinical data analytics solution that enables healthcare organizations to unlock insights from vast amounts of structured and unstructured data. Leveraging Mendel's proprietary AI that couples large language models with a clinical hypergraph, Hypercube transforms fragmented data into meaningful clinical insights, accelerating research and improving patient care. Leading life science companies use Hypercube for patient recruitment, patient cohort identification, chart review, and analytical queries."Our collaboration with Microsoft Azure marks a significant milestone for Mendel as we expand the accessibility of our Hypercube Platform," said Dr. Karim Galil, CEO of Mendel

Hypercube Platform From Mendel Now Available In The Microsoft Azure Marketplace

Empowering life science organizations to unlock the power of generative AI with 100% explainability and limited hallucinationsSAN JOSE, Calif., Aug. 20, 2024 /PRNewswire/ -- Mendel announced today that it has joined Google Cloud Partner Advantage as a Partner level partner for the Build Engagement Model, giving customers the ability to access Hypercube on Google Cloud Marketplace.As a Google Cloud partner, Mendel offers healthcare and life science customers a suite of AI-powered tools designed to transform clinical data analytics workflows. Mendel's Hypercube leverages an AI platform that couples large language models with a clinical hypergraph to unlock the vast potential of clinical data warehouses, enabling life science organizations to make more informed, data-driven decisions and improve patient outcomes.Key features of Mendel's Hypercube platform include:Hypercube Cohort : Rapidly create and refine patient cohorts with 5x increase in accuracy and scale.: Rapidly create and refine patient cohorts with 5x increase in accuracy and scale. Hypercube Charts : Chat with medical records through a user-friendly interface, completing chart reviews with 30%+ more efficiency.: Chat with medical records through a user-friendly interface, completing chart reviews with 30%+ more efficiency. Hypercube Analyst : Query clinical data with a low-code interface, enabling 10x faster querying.: Query clinical data with a low-code interface, enabling 10x faster querying. Hypercube Redact: De-identify and tokenize patient records with >99% accuracy.De-identify and tokenize patient records with >99% accuracy

Mendel Joins Google Cloud Partner Advantage And Delivers Hypercube Through Google Cloud Marketplace

Mendel AI is developing clinically focused AI solutions that can understand nuances in medical data at scale to provide actionable insights, with applications across clinical research, real-world evidence generation and cohort selection.

Gen AI Healthcare Accelerated: Dozens of Companies Adopt Meta Llama 3 NIM

Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Digital Health For Obesity Market Size, Share & Trends Analysis Report By Component (Hardware, Software, Services), By End-use (Patients, Providers, Payers), By Region, And Segment Forecasts, 2024 - 2030" report has been added to ResearchAndMarkets.com's offering.The global digital health for obesity market size is anticipated to reach USD 196.8 billion by 2030 and is projected to grow at a CAGR of 22.8% from 2024 to 2030.Rising global obesity rates, with over 1.9 billion adults affected, have created a substantial market demand for weight management solutions. Lifestyle changes, including sedentary habits and unhealthy dietary choices, contribute significantly to this growth. The increasing awareness of obesity-related health risks, such as diabetes and cardiovascular diseases, propels individuals toward seeking effective interventions. In addition, advancements in technology and the emergence of digital health solutions, personalized dietary guidance apps, and wearable devices, further drive market growth as people increasingly turn to technology for managing their weight. The intersection of health consciousness, technological innovation, and the urgent need for effective weight management solutions collectively fuels the market growth.Furthermore, the growth of digital health solutions in obesity market can be attributed to a rising prevalence of obesity and associated health conditions, alongside growing health awareness. Incorporating advanced technologies such as artificial intelligence (AI) and machine learning (ML) is anticipated to further contribute to market expansion

Digital Health For Global Obesity Market Analysis Report 2024-2030, Featuring Myfitnesspal, Teladoc, Fitnesskeeper, Platejoy, Tempus, Fitbit, Noom, Welldoc, Sidekick Health And Bioage Labs

Mendel launches Hypercube, an ai-copilot for real world data applications.

Mendel Launches Hypercube, an AI-Copilot for Real World Data Applications

DUBLIN, Aug. 25, 2023 /PRNewswire/ -- The "Global AI in Clinical Trials Market: Trends and Forecasts 2023-2035" report has been added to ResearchAndMarkets.com's offering.The global AI in clinical trials market is estimated to be worth $ 1.4 billion in 2023 and expected to grow at compounded annual growth rate (CAGR) of 16% during the forecast period.The process of successfully developing a novel therapeutic intervention is both time and cost intensive. In fact, it is estimated that a drug requires around 10 years and over $ 2.5 billion capital investment, before reaching the market. In this process, clinical trials play a crucial role for assessing the drug's efficacy and safety in humans. These trials account for nearly 50% of the time and capital expenditure during drug development. However, sponsors face financial burdens and significant delays in marketing drugs due to unsuccessful clinical trials.Over the past few decades, the success rate of a drug candidate advancing the clinical trials to obtaining marketing approval has remained relatively constant at approximately 10% - 20%

Analysis Of The Global Ai In Clinical Trials Industry, 2023 To 2035 - Product/Technology Utilization And Integration Agreements Lead The Way In Partnerships

DUBLIN--(BUSINESS WIRE)--The "AI-based Clinical Trials Solution Provider Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's offering. The report on the global AI-based clinical trials solution provider market provides qualitative and quantitative analysis for the period from 2020 to 2028. The report predicts the global AI-based clinical trials solution provider market to grow with a CAGR of about 23% over the forecast period from 2022-2028. The study on AI-based clinical trials solution provider market covers the analysis of the leading geographies such as North America, Europe, APAC and RoW for the period of 2020 to 2028

Ai-Based Clinical Trials Solution Provider Market: Global Industry Analysis, Trends, Market Size, And Forecasts Up To 2028 - Researchandmarkets.Com

AI-driven clinical data analysis for oncology

Mendel.ai

AI-driven clinical data analysis for oncology

Mendel.ai

AI-driven clinical data analysis for oncology

About

Simplify's Take

What believers are saying

What critics are saying

What makes Mendel.ai unique

6 month growth

1 year growth

2 year growth

Benefits

Recently Posted Jobs

Mendel.ai is Hiring for 0 Jobs on Simplify!